Genetics of multiple sclerosis

Lancet Neurology

Volumn 3, Issue 2, 2004, Pages 104-110

  Dyment, David A ^a   Ebers, George C ^a   Sadovnick, A Dessa ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADOPTION; CONSANGUINEOUS MARRIAGE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; FAMILY; GENETIC HETEROGENEITY; HUMAN; MARRIAGE; MICROENVIRONMENT; MOLECULAR GENETICS; MULTIPLE SCLEROSIS; OUTCOMES RESEARCH; PEDIGREE; POPULATION RESEARCH; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SIBLING; TWINS;

EID: 1642513783     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00663-X     Document Type: Review

References (125)

1. Keegan B.M., Noseworthy J.H. Multiple sclerosis. Ann Rev Med. 53:2002;285-302.
2. Peterson J.W., Bo L., Mork S., Chang A., Trapp B.D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 50:2001;389-400.
3. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain. 120:1997;393-399.
4. Trapp B.D., Peterson J., Ransohof R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 338:1998;278-285.
5. Confavreux C., Vukusic S., Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnestic process. Brain. 126:2003;770-782.
6. Lassmann H., Bruck W., Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med. 7:2001;115-121.
7. Eichhorst H. Veber infantile und hereditare multiple sklerosis. Arch Pathol Anat Physiol Klin Med. 146:1896;173-192.
8. Mackay R.P. The familial occurrence of multiple sclerosis and its implications. Res Publ Assoc Res Nerv Ment Dis. 28:1950;149-177.
9. Jersild C., Svejgaard A., Fog T. HLA antigens and multiple sclerosis. Lancet. 2:1972;1240-1241.
10. Naito S., Namerow N., Mickey M., Teraski P. Multiple Sclerosis: association with HL-A3. Tissue Antigens. 2:1972;1-4.
11. Sadovnick A.D., Baird P.A., Ward R.H. Multiple Sclerosis: updated risks for relatives. Am J Med Genet. 29:1988;533-541.
12. Robertson N.P., Fraser M., Deans J., Clayton D., Walker N., Compston DAS. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain. 119:1996;449-455.
13. Carton H., Vlietinck R., Debruyne J., et al. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry. 62:1997;329-333.
14. Montomoli C., Prokopenko I., Caria A., et al. Multiple sclerosis recurrence risk for siblings in an isolated population of central Sardinia, Italy. Genet Epidemiol. 22:2002;265-271.
15. Sadovnick A.D., Bulman D.E., Hashimoto L., D'Hooghe M.B., Ebers G.C. The influence of gender on the susceptibility to multiple sclerosis in sibships. Arch Neurol. 48:1991;586-588.
16. Bulman D.E., Sadovnick A.D., Cripps J., Ebers G.C. Age of onset in siblings concordant for multiple sclerosis. Brain. 114:1991;937-950.
17. Sadovnick A.D., Yee I.M.L., Ebers G.C., Risch N.J. The effect of age onset and parental disease status on sib risks for multiple sclerosis. Neurology. 50:1998;719-723.
18. Sadovnick AD, Yee IML, Ebers GC and the Canadian Collaborative Study Group. Factors influencing sib risks for MS. Clin Genet 2000; 58: 431-35.
19. Willer C.J., Dyment D.A., Sadovnick A.D., Risch N.J., Ebers G.E. Twin concordance and sibling recurrence rates in multiple sclerosis: The Canadian Collaborative Study. Proc Natl Acad Sci USA. 100:2003;12877-12882.
20. Sadovnick A.D., Dircks A., Ebers G.C. Genetic counselling in multiple sclerosis. Clin Genet. 56:1999;118-122.
21. Hawkes C.H. Is multiple sclerosis a sexually transmitted infection? J Neurol Neurosurg Psychiatry. 73:2002;439-443.
22. Ebers GC, Sadovnick AD, Risch NJ, and the Canadian Collaborative Study Group. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995; 377: 150-51.
23. Vogel F., Motulsky A. Human genetics: problems and approaches. 1979;Springer-Verlag, Berlin.
24. Gottesman I. Complications to the complex inheritance of schizophrenia. Clin Genet. 46:1994;116-123.
25. Sadovnick AD, Ebers GC, Dyment D, Risch NJ and the Canadian Collaborative Study Group. Evidence for the genetic basis of multiple sclerosis. Lancet 1996: 347: 1728-30.
26. Risch N. Linkage strategies for genetically complex traits, I: multilocus models. Am J Hum Genet. 46:1990;222-228.
27. Galton F. "History of twins" in human faculty and its development. 1883;McMillan and Co, London.
28. Curtius F., Speer H. Multiple sklerose und eranlage. Z Gesamte Neurol Psychiatr. 160:1937;226-245.
29. Das Thums K. Erblichkeitsproblem bei der Multiplen Sklerose. Munchen Med Wochenschr. 86:1939;1634-1638.
30. Mackay R.P., Myrianthopoulos N.C. Multiple sclerosis in twins and their relatives: final report. Arch Neurol. 15:1966;449-462.
31. Bammer H., Schaltenbrand G., Solcher H. Zwillingsuntersuchungen bei Multipler Sklerose. Dtsch Z Nervenheilk. 181:1960;261-279.
32. Cendrowsi W.S. Multiple sclerosis: discordance in three pairs of dizygotic twins. J Med Genet. 5:1968;266-268.
33. Gardner-Thorpe C., Foster J.B. Monozygous twins discordant for multiple sclerosis: report of one pair and discussion of possible causes of multiple sclerosis. J Neurol Sci. 26:1975;361-375.
34. Bobowick A.R., Kurtzke J.F., Brody J.A., Hrubec Z., Gillespie M. Twin Study of multiple sclerosis: an epidemiological inquiry. Neurology. 28:1978;978-987.
35. Williams A., Eldridge R., McFarland H., Houff S., Krebs H., McFarlin D. Multiple sclerosis in twins. Neurol. 30:1980;1139-1147.
36. Currier R.D., Eldridge R. Possible risk factors in multiple sclerosis as found in a national twin Study. Arch Neurol. 39:1982;140-144.
37. Heltberg A., Holm N. Concordance in twins and recurrence in sibships in multiple sclerosis. Lancet. 1:1982;1068.
38. Kinnunen E., Koskenvuo M., Kaprio J., Aho K. Multiple sclerosis in a nationwide series of twins. Neurology. 37:1987;1627-1629.
39. Kinnunen E., Juntunen J., Ketonen L., et al. Genetic susceptibility to multiple sclerosis: a co-twin study of a nationwide series. Arch Neurol. 45:1988;1108-1111.
40. Multiple sclerosis in 54 twinships: concordance rate is independent of zygosity. Ann Neurol. 32:1992;724-727.
41. Mumford C.J., Wood N.W., Kellar-Wood H., Thorpe J.W., Miller D.H., Compston D.A. The British Isles survey of multiple sclerosis in twins. Neurology. 44:1994;11-15.
42. Ebers G.C., Bulman D.E., Sadovnick A.D., et al. A population-based study of multiple sclerosis in twins. New Engl J Med. 315:1986;1638-1642.
43. Sadovnick A.D., Armstrong H., Rice G.P.A., et al. A population-based study of Multiple Sclerosis in twins: update. Ann Neurol. 33:1993;281-285.
44. Schapira K., Poskanzer D.C., Millar H. Familial and conjugal multiple sclerosis. Brain. 86:1966;315-332.
45. Ebers G.C., Sadovnick A.D. The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol. 54:1994;1-17.
46. Robertson N.P., O'Riordan J.I., Chataway J., et al. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet. 349:1997;1587-1590.
47. Ebers GC, Yee IML, Sadovnick AD, Duquette P and the Canadian Collaborative Study Group. Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Ann Neurol 2000; 48: 927-31.
48. Sadovnick AD, Yee IML, Ebers GC and the Canadian Collaborative Study Group. Recurrence risks to sibs of MS index cases: impact of consanguineous mating. Neurology 2001; 56: 784-85.
49. O'Connor P on behalf of the Canadian Multiple Sclerosis Working Group. Key issues in the diagnosis and treatment of multiple sclerosis. Neurology 2002; 59 (suppl 3): S1-33.
50. Voulgari P.V., Katsimbri P., Alamanos Y., Drosos A.A. Gender and age differences in systemic lupus erythematosus: a study of 489 Greek patients with a review of the literature. Lupus. 11:2002;722-729.
51. Symmons D.P. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol. 16:2002;707-722.
52. Duquette P., Murray T.J., Pleines J., et al. Multiple Sclerosis in childhood: clinical profile in 125 patients. J Pediat. 111:1987;359-363.
53. Boiko A, Vorobeychik G, Paty DW, Sadovnick AD, and the UBC MS Clinic Neurologists. Natural history of multiple sclerosis in children: longitudinal study in British Columbia, Canada. Neurology 2002, 59: 1006-10.
54. Cottrell D.A., Rice G.P.A., Hader W., Baskerville J., Koopman W.J., Ebers G.C. The natural history of multiple sclerosis: a geographically based study, 5: the clinical features and natural history of primary progressive multiple sclerosis. Brain. 122:1999;625-639.
55. Willer C.J., Sadovnick A.D., Ebers G.C. Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis. J Neuroimmunol. 126:2002;126-133.
56. Colhoun H.M., McKeigue P.M., Davie-Smith G. Problems of reporting genetic associations with complex outcomes. Lancet. 361:2003;865-872.
57. Dyment D., Sadovnick A.D., Ebers G.C. Genetics of multiple sclerosis. Hum Mol Genet. 6:1997;1693-1698.
58. University of California at San Francisco. Multiple sclerosis candidate genes: research papers. http://www.ucsf.edu/msdb/r_ms_candidate_genes.html (accessed Jan 5, 2004).
59. Olerup O., Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 38:1991;1-15.
60. Sotgiu S., Rosati G., Saana A., et al. Multiple sclerosis complexity in selected populations: the challenge of Sardinia, insular Italy. Eur J Neurol. 9:2002;1-13.
61. Jersild C., Hansen C., Svejgaard A., Fog T., Thomsen M., Dupont B. Histocompatability determinants in multiple sclerosis with special reference to clinical course. Lancet. 2:1973;1221-1225.
62. Winchester R.J., Ebers G.C., Fu S.M., Espinosa L., Zabriskie J., Kunkel H.G. B-cell Alloantigen 7a in multiple sclerosis. Lancet. 2:1975;84.
63. Fogdell A., Hillert J., Sachs C., Olerup O. The multiple sclerosis- and narcolepsy- associated HLA class II haplotype includes DRB5*0101 allele. Tissue Antigens. 46:1995;333-336.
64. Tiwari J.L., Teraskai P.I. HLA and disease associations. 1985;Springer-Verlag, New York.
65. Ligers A., Dyment D.A., Willer C., et al. The genetic contribution of the HLA DRB1 locus to MS susceptibility. Am J Hum Genet. 69:2001;900-903.
66. Spurkland A., Ronningen K., Vandvik B., Thorsby E., Vartdal F. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Hum Immunol. 30:1991;69-75.
67. Marrosu M.G., Murru M.R., Costa G., et al. Multiple sclerosis in Sardinia is associated and in linkage-disequilibrium with HLA-DR3 and -DR4 alleles. Am J Hum Genet. 61:1997;454-457.
68. Marrosu M.G., Murru R., Murru M.R., et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet. 10:2001;2907-2916.
69. Corradu F., Reyes Yanez M.P., Parra A., et al. HLA associations with multiple sclerosis in the Canary Islands. J Neuroimmunol. 87:1998;130-135.
70. Saruhan-Direskeneli G., Esin S., Baykan-Kurt B., Ornek I., Vaughan R., Eraksoy M. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol. 55:1997;59-65.
71. Caballero A., Alves-Leon S., Papais-Alvarenga R., Fernandez O., Navarro G., Alonso A. DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians. Tissue Antigens. 54:1999;524-526.
72. Mignot E., Lin X., Rogers W., et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet. 68:2001;686-699.
73. Mignot E., Thorsby E. Narcolepsy and the HLA system. N Engl J Med. 343:2001;782-786.
74. Haines J.L., Bradford Y., Garcia M.E., et al. Multiple susceptibility loci for multiple sclerosis. Hum Mol Genet. 11:2002;2251-2256.
75. Rubio J.O., Bahlo M., Butzkueven H., et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet. 70:2002;1125-1137.
76. Boon M., Nolte I.M., Bruinenberg M., et al. Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis. Neurogenetics. 3:2001;221-230.
77. Fogdell-Hahn A., Ligers A., Grønning M., Hillert J., Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens. 55:2000;140-148.
78. Celius E.G., Harbo H.F., Egeland T., Vartdal F., Vandvik B., Spurkland A. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J Neurol Sci. 178:2000;132-135.
79. Runmarker B., Martinsson T., Wahlstrom J., Andersen O. HLA and prognosis in multiple sclerosis. J Neurol. 241:1994;385-390.
80. Hensiek A.E., Sawcer S.J., Feakes R., et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry. 72:2002;184-187.
81. Olerup O., Hillert J., Fredrikson S., et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA. 86:1989;7113-7117.
82. Lynch S.G., Rose J.W., Petajan J.H., Stauffer D., Kamerath C., Leppert M. Discordance of T cell receptor in familial multiple sclerosis. Ann Neurol. 30:1991;402-410.
83. Hillert J., Leng C., Olerup O. No Association with germline T cell receptor B chain alleles or haplotypes in Swedish patients with multiple sclerosis. J Neuroimmunol. 31:1999;141-147.
84. Wei S., Charmley P., Birchfield R., Concaanon P. Human T cell receptor Vb gene polymorphism and multiple sclerosis. Am J Hum Gen. 56:1995;963-969.
85. Beall S., Biddison W., McFarlin D., McFarland H., Hood L. Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR V beta chain locus and HLA class II genes. J Neuroimmunol. 45:1993;53-60.
86. Epplen C., Jackel S., Santos E., et al. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Neurology. 41:1997;341-352.
87. Buhler M.M., Bennets B.H., Heard R.N.S., Stewart G.J. T cell receptor beta chain genotyping in Australian relapsing-remitting multiple sclerosis patients. Mult Scler. 6:2000;140-147.
88. Seboun E., Robinson M.A., Doolittle T.H., Ciulla T.A., Kindt T.J., Hauser S.L. A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell. 57:1989;1095-1100.
89. Hockertz M., Paty D., Beall S. Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TCR β locus: use of the affected family-based controls. Am J Hum Genet. 62:1998;373-385.
90. Pozzilli P., Buzzetti R., Nistico L., Romiti A., Giovannini C. Non-HLA genes and the susceptibility to insulin dependent diabetes: the role of the CTLA-4 gene. Acta Diabetol. 33:1996;250-252.
91. Donner H., Rau H., Walfish P.G., et al. CTLA4 alanine-17 confers genetic susceptibility to Graves disease and to type 1 diabetes mellitus. J Clin Endocrin Metab. 82:1997;143-146.
92. Kotsa K., Watson P.F., Weetman A.P. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune thyroidism. Clin Endo. 46:1997;551-554.
93. Ueda H., Howson J.M., Esposito L., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423:2003;506-511.
94. Harbo H.F., Celius E.G., Vartdal F., Spurkland A. CTLA4 promotor and exon 1 dimorphsims in multiple sclerosis. Tissue Antigens. 53:1999;106-110.
95. Ligers A., Xu C., Saarinen S., Hillert J., Olerup O. The CTLA4 gene is associated with multiple sclerosis. J Neuroimmunol. 97:1999;182-190.
96. Kantarci O.H., Hebrink D.D., Achenbach S.J., et al. CTLA4 is associated with susceptibility to multiple sclerosis. J Neuroimmunol. 139:2003;133-142.
97. Dyment D.A., Steckley J.L., Willer C.J., et al. CTLA-4 is not a susceptibility locus in Canadian families. J Neuroimmunol. 123:2002;193-198.
98. Mycko M.P., Kwinkowski M., Tronczynska E., Szymanska B., Selmaj K.W. Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol. 44:1998;70-75.
99. Nejentsev S., Laaksonen M., Tienari P.J., et al. Intracellular Adhesion Molecule-1 K469E Polymorphism: Study of association with multiple sclerosis. Hum Immunol. 64:2003;345-349.
100. Dai K.Z., Harbo H.F., Celius E.G., et al. The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun. 2:2001;263-268.
101. Ebers G., Kukay K., Bulman D., et al. A full genome search in multiple sclerosis. Nat Genet. 13:1996;472-476.
102. Haines J, Pericak-Vance M, Seboun E, Hauser S and the Multiple Sclerosis Genetics Group. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nat Genet 1996; 13: 469-71.
103. Sawcer S., Jones H., Feakes R., et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet. 13:1996;464-468.
104. Kuokkanen S., Sundvall M., Terwilliger J., et al. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat Genet. 13:1996;477-480.
105. Broadley S., Sawcer S., D'Alfonso S., et al. A genome screen for multiple sclerosis in Italian families. Gene Immun. 4:2001;205-210.
106. Corradu F., Sawcer S., D'Alfonso S., et al. A genome screen for multiple sclerosis in Sardinian multiplex families. Euro J Hum Genet. 19:2001;621-626.
107. Ban M., Stewart G.J., Bennetts B.H., et al. A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun. 3:2002;464-469.
108. Akesson E., Oturai A., Berg J., et al. A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun. 3:2002;279-285.
109. Chataway J., Sawcer S., Feakes R., et al. A screen of candidates from peaks of linkage: evidence for involvement of myeloperoxidase in multiple sclerosis. J Neuroimmunol. 98:1999;208-213.
110. Larsen F., Otviai A., Ryder L.P., et al. Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q. Genes Immun. 1:2000;456-459.
111. Dyment D.A., Willer C.J., Scott B., et al. Genetic susceptibility to MS: a second stage analysis in Canadian families. Neurogenetics. 3:2001;145-151.
112. Saarela J., Fejzo Schoenberg M., Chen D., et al. Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24. Hum Mol Genet. 11:2002;2257-2267.
113. Reunanen K., Finnila S., Laaksonen M., et al. Chromosome 19q13 and multiple sclerosis susceptibility in Finland: a linkage and two-stage association study. J Neuroimmunol. 126:2002;134-142.
114. Sadovnick AD, Ebers GC, Risch NJ and the Canadian Collaborative Study Group. Canadian Collaborative Project on Genetic Susceptibility to MS, phase 2: rationale and method. Can J Neurol Sci 1998; 25: 216-21.
115. A meta-analysis of genomic screens in multiple sclerosis. Mult Scler. 7:2001;3-11.
116. Sadovnick A.D. Genetic counselling in dementia. Qizilbash N., Schneider L., Chui H., et al. Evidence-based dementia: a practical guide to diagnosis and management (with internet updates). 2002;795-800 Blackwells, Oxford.
117. Nicholl D.J., Vaughan J.R., Khan N.L., et al. Two large British kindreds with familial Parkinson's disease: a clinico-pathological and genetic study. Brain. 125:2002;44-57.
118. Vitale E., Cook S., Sun R., et al. Linkage analysis conditional on HLA status in a large North American pedigree supports the presence of a multiple sclerosis susceptibility locus on chromosome 12p12. Hum Mol Genet. 11:2002;295-300.
119. He B., Giedraitis V., Ligers A., et al. Sharing of a conserved haplotype suggests a susceptibility gene for multiple sclerosis at chromosome 17p11. Eur J Hum Genet. 10:2002;271-275.
120. Modin H., Masterman T., Thorlacius T., et al. Genome-wide linkage screen of a consanguineous multiple sclerosis kinship. Mult Scler. 9:2003;128-134.
121. Dyment D.A., Steckley J.L., Willer C.J., Armstrong H., Sadovnick A.D., Ebers G.C. An extended pedigree with multiple sclerosis suggests autosomal dominant inheritance. Brain. 125:2002;1-9.
122. Sawcer S., Maranian M., Setakis E., et al. A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain. 125:2002;1337-1347.
123. Goedde R., Sawcer S., Bochringer S., et al. A genome scan for linkage disequilibrium in HLA DRB1*15-positive Germans with multiple sclerosis based on 4666 microsatellite markers. Hum Genet. 111:2002;270-277.
124. Abecasis G.R., Noguchi E., Heinzman A., et al. Extent and distribution of linkage disequilibrium in 3 genomic regions. Am J Hum Genet. 68:2001;191-197.
125. Lock C., Hermans G., Pedottii R., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 8:2002;500-508.